Glioma targeting was obtained via CDX peptide (FKESWREARGTRIERG) expression on mouse embryonic fibroblast EVs for U87 tumor cell targeting, and CREKA peptide expression on mouse bone marrow derived DC EVs for GL261 tumor cell targeting, via fusion to the N-terminal of the abundant CD47 transmembrane protein. The gene discussed is CD47; the disease is neoplasm.